Inherited predisposition to cancer: A historical overview

American Journal of Medical Genetics - Seminars in Medical Genetics

Volumn 129 C, Issue 1, 2004, Pages 5-22

  Lynch, Henry T ^a,b   Shaw, Trudy G ^a   Lynch, Jane F ^a  

^a Department of Medicine ^*

^b CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Amsterdam criteria; Amsterdam II criteria; Bethesda Guidelines; Genetic counseling; Germline mutations; Hereditary breast ovarian cancer syndrome; Hereditary cancer syndromes; History; Lynch syndrome; Molecular genetics; Neurofibromatosis

Indexed keywords

BREAST CANCER; CANCER SUSCEPTIBILITY; CLUSTER ANALYSIS; COLORECTAL CANCER; FAMILIAL CANCER; GENE MUTATION; GENETIC DISORDER; HIGH RISK PATIENT; HUMAN; INBRED STRAIN; INHERITANCE; MASTECTOMY; MISMATCH REPAIR; MULTIGENE FAMILY; MULTIPLE ENDOCRINE NEOPLASIA; NEUROFIBROMATOSIS; NONHUMAN; OVARIECTOMY; OVARY CANCER; PANCREAS CANCER; PRIORITY JOURNAL; PROPHYLAXIS; PROTO ONCOGENE; REVIEW;

EID: 3342933003     PISSN: 15524868     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajmg.c.30026     Document Type: Review

References (223)

1. Aaltonen LA, Peltomaki P, Leach FS, Sistonen P, Pylkkanen L, Mecklin J-P, Jarvinen H, Powell SM, Jen J, Hamilton SR, Petersen GM, Kinzler KW, Vogelstein B, de la Chapelle A. 1993. Clues to the pathogenesis of familial colorectal cancer. Science 260:812-816.
2. Akiyama Y, Sato H, Yamada T, Nagasaki H, Tsuchiya A, Abe R, Yuasa Y. 1997. Germline mutation of the hMSH6/GTBP gene in an atypical hereditary nonpolyposis colorectal cancer kindred. Cancer Res 57:3920-3923.
3. Albano WA, Recabaren JA, Lynch HT, Campbell AS, Mailliard JA, Organ CH, Lynch JF, Kimberling WJ. 1982. Natural history of hereditary cancer of the breast and colon. Cancer 50:360-363.
4. Aldrovandi U. 1642. Monstrorum historia cum paralipomenis historiae omnium animalium. Bononaiae: Typis Nicolai Tibaldini [Latin].
5. Arvanitis ML, Jagelman DG, Fazio VN, Lavery IC, McGannon E. 1990. Mortality in patients with familial adenomatous polyposis. Dis Colon Rectum 33:639-642.
6. Ascoli V, Aalto Y, Carnovale-Scalzo C, Nardi F, Falzetti D, Mecucci C, Knuutila S. 2001. DNA copy number changes in familial malignant mesothelioma. Cancer Genet Cytogenet 127:80-82.
7. Balmain A, Gray J, Ponder B. 2003. The genetics and genomics of cancer. Nat Genet 33(Suppl):238-244.
8. Bartsch DK. 2003. Familial pancreatic cancer. Br J Surg 90:386-387.
9. Beghini A, Tibiletti MG, Roversi G, Chiaravalli AM, Serio G, Capella C, Larizza L. 2001. Germline mutation in the juxta-membrane domain of the kit gene in a family with gastrointestinal stromal tumors and urticaria pigmentosa. Cancer 92:657-662.
10. Bickersteth RA. 1890. Multiple polypi of the rectum occurring in a mother and child. St. Bartholomew's Hosp Rep 26:299-301.
11. Bodmer WF, Bailey CJ, Bodmer J, Bussey HJR, Ellis A, Gorman P, Lucibello FC, Murday VA, Rider SH, Scambler P, Sheer D, Solomon E, Spurr NK. 1987. Localization of the gene for familial adenomatous polyposis on chromosome 5. Nature 328:614-616.
12. Boland CR. 1996. Roles of the DNA mismatch repair genes in colorectal tumorigenesis. Int J Cancer 69:47-49.
13. Boland CR, Troncale FJ. 1984. Familial colonic cancer without antecedent polyposis. Ann Intern Med 100:700-701.
14. Boland CR, Chen YF, Rinderle SJ, Resau JH, Luk GD, Lynch HT, Goldstein IJ. 1991. Use of the lectin from Amaranthus caudatus as a histochemical probe of proliferating colonic epithelial cells [published erratum appears in Cancer Res 1992;52:4066]. Cancer Res 51: 657-665.
15. Boland CR, Chen YF, Rinderle SJ, Resau JH, Luk GD, Lynch HT, Goldstein IJ. 1991. Use of the lectin from Amaranthus caudatus as a histochemical probe of proliferating colonic epithelial cells [published erratum appears in Cancer Res 1992;52:4066]. Cancer Res 51: 657-665.
16. Boland CR, Martin MA, Goldstein IJ. 1992. Lectin reactivities as intermediate biomarkers in premalignant colorectal epithelium. J Cell Biochem 16G:103-109.
17. Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, Meltzer SJ, Rodriguez-Bigas MA, Fodde R, Ranzani GN, Srivastava S. 1998. A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58:5248-5257.
18. Bottomley RH, Condit PT. 1968. Cancer families. Cancer Bull 20:22-24.
19. Bottomley RH, Condit PT, Chanes RE. 1967. Cytogenctic studies in familial malignancy. Clin Res 15:334 (abstract).
20. Bottomley RH, Trainer AL, Condit PT. 1971. Chromosome studies in a "cancer family". Cancer 28:519-528.
21. Broca PP. 1866. Traité des tumeurs. Vol. 1, 2. Paris: Asselin.
22. Bronner CE, Baker SM, Morrison PT, Warren G, Smith LG, Lescoe MK, Kane M, Earabino C, Lipford J, Lindblom A, Tannergard P, Bollag RJ, Godwin AR, Ward DC, Nordenskjold M, Fishel R, Kolodner R, Liskay RM. 1994. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary nonpolyposis colon cancer. Nature 368:258-261.
23. Bulow S, Lauritsen KB, Johansen A, Svendsen LB, Sondergaard JO. 1985. Gastroduodenal polyps in familial polyposis. Dis Colon Rectum 28:90-93.
24. Bussey HJR. 1990. Historical developments in familial adenomatous polyposis. In: Herrera L, editor. Familial adenomatous polyposis. New York: Alan R. Liss, Inc. p. 1-7.
25. Caldas C, Hahn SA, da Costa LT, Redston MS, Schutte M, Seymour AB, Weinstein CL, Hruban RH, Yeo CJ, Kern SE. 1994. Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nat Genet 8: 27-32.
26. Cawley EP. 1952. Genetic aspects of malignant melanoma. Arch Derm Syph 65:440-450.
27. Chang DK, Goel A, Ricciardiello L, Lee DH, Chang CL, Carethers JM, Boland CR. 2003. Effect of H(2)O(2) on cell cycle and survival in DNA mismatch repair-deficient and -proficient cell lines. Cancer Lett 195: 243-251.
28. Church JM. 1996. Prophylactic colectomy in patients with hereditary nonpolyposis colorectal cancer. Ann Med 28:479-482.
29. Clark WH Jr, Reimer RR, Greene M, Ainsworth AM, Mastrangelo MJ. 1978. Origin of familial malignant melanomas from heritable melanocytic lesions. "The B-K mole syndrome". Arch Dermatol 114:732-738.
30. Cote GJ, Gagel RF. 2003. Lessons learned from the management of a rare genetic cancer. N Engl J Med 349:1566-1568.
31. Cripps WH. 1882. Two cases of disseminated polyps of the rectum. Trans Pathol Soc London 33:165-168.
32. Cristofaro G, Lynch HT, Caruso ML, Attolini A, DiMatteo G, Giorgio P, Senatore S, Argentieri A, Sbano E, Guanti G, Fusaro R, Giorgio I. 1987. New phenotypic aspects in a family with Lynch syndrome II. Cancer 60:51-58.
33. de la Chapelle A, Wright FA. 1998. Linkage disequilibrium mapping in isolated populations: the example of Finland revisited. Proc Natl Acad Sci USA 95:12416-12423.
34. de vos tot Nederveen Cappel WH, Offerhaus GJA, van Pujenbroek M, Caspers E, Gruis NA, de Snoo EA, Lamers CBHW, Griffioen G, Bergman W, Vasen HFA, Morreau H. 2003. Pancreatic carcinoma in carriers of a specific 19 base pair deletion of CDKN2A/p16 (p16-Leiden). Clin Cancer Res 9:3598-3605.
35. Demetri GD, von Mehren M, Blanke CD, Van den Abbeele AD, Eisenberg B, Roberts PJ, Heinrich MC, Tuveson DA, Singer S, Janicek M, Fletcher JA, Silverman SG, Silberman SL, Capdeville R, Kiese B, Peng B, Dimitrijevic S, Druker BJ, Corless C, Fletcher CDM, Joensuu H. 2002. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 347:472-480.
36. Donis-Keller H, Dou S, Chi D, Carlson KM, Toshima K, Lairmore TC, Howe JR, Moley JF, Goodfeflow P, Wells SA. 1993. Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. Hum Mol Genet 2:851-856.
37. Druker BJ, Sawyers CL, Kantarjian H, Resta DJ, Reese SF, Ford JM, Capdeville R, Talpaz M. 2001a. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. N Engl J Med 344: 1038-1042.
38. Druker BJ, Talpaz M, Resta DJ, Peng B, Buchdunger E, Ford JM, Lydon NB, Kantarjian H, Capdeville R, Ohno-Jones S, Sawyers CL. 2001b. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med 344:1031-1037.
39. Eberle MA, Pfützer R, Pogue-Geile KL, Bronner MP, Crispin D, Kimmey MB, Duerr RH, Kruglyak L, Whitcomb DC, Brentnall TA. 2002. A new susceptibility locus for autosomal dominant pancreatic cancer maps to chromosome 4q32-34. Am J Hum Genet 70:1044-1048.
40. Fishel R, Lescoe MK, Rao MKS, Copeland NG, Jenkins NA, Garber J, Kane M, Kolodner R. 1993. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 75:1027-1038.
41. Fusaro RM, Lynch HT, Pester J, Lynch PM. 1980. Torre's syndrome as phenotypic expression of cancer family syndrome. Arch Dermatol 116:986-987.
42. Gagel RF, Tashjian AH Jr, Cummings T, Papathanasopoulos N, Kaplan MM, DeLellis RA, Wolfe HJ, Reichlin S. 1988. The clinical outcome of prospective screening for multiple endocrine neoplasia type 2a: an 18-year experience. N Engl J Med 318: 478-484.
43. Gardner EJ, Richards RC. 1953. Multiple cutaneous and subcutaneous lesions occurring simultaneously with hereditary polyposis and osteomatosis. Am J Hum Genet 5:139-147.
44. Giardiello FM, Offerhaus GJ, Lee DH, Krush AJ, Tersmette AC, Booker SV, Kelley NC, Hamilton SR. 1993. Increased risk of thyroid and pancreatic carcinoma in familial adenomatous polyposis. Gut 34: 1394-1396.
45. Giardiello FM, Brensinger JD, Tersmette AC, Goodman SN, Petersen GM, Booker SV, Cruz-Correa M, Offerhaus JA. 2000. Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology 119: 1447-1453.
46. Goggins M, Schutte M, Lu J, Moskaluk CA, Weinstein CL, Petersen GM, Yeo CJ, Jackson CE, Lynch HT, Hruban RH, Kern SE. 1996. Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas. Cancer Res 56: 5360-5364.
47. +. Am J Pathol 152:1501-1507.
48. Goldstein AM, Tucker MA. 1997. Screening for CDKN2A mutations in hereditary melanoma. J Natl Cancer Inst 89:676-678.
49. INK4 mutations. N Engl J Med 333:970-974.
50. Goldstein AM, Struewing JP, Chidambaram A, Fraser MC, Tucker MA. 2000. Genotype-phenotype relationships in U.S. melanoma-prone families with CDKN2A and CDK4 mutations. J Natl Cancer Inst 92:1006-1010.
51. Green EL, editor. 1966. Biology of the laboratory mouse. 2nd ed. New York: Blakiston Division, McGraw-Hill.
52. Groden J, Thliveris A, Samowitz W, Carlson M, Gelbert L, Albertsen H, Joslyn G, Stevens J, Spirio L, Robertson M, Sargeant L, Krapcho K, Wolff E, Burt R, Hughes JP, Warrington J, McPherson J, Wasmuth J, Le Paslier D, Abderrahim H, Cohen D, Leppert M, White R. 1991, Identification and characterization of the familial adenomatous polyposis coli gene. Cell 66:589-600.
53. Hall JM, Lee MK, Newman B, Morrow JE, Anderson LA, Huey B, King MC. 1990. Linkage of early-onset breast cancer to chromosome 17q21. Science 250:1684-1689.
54. Happle R. 1997. A rule concerning the segmental manifestations of autosomal dominant skin disorders: Review of clinical examples providing evidence for dichotomous types of severity. Arch Dermatol 133:1505-1509.
55. Harris RE, Lynch HT, Guirgis HA. 1978. Familial breast cancer: risk to the contralateral breast. J Natl Cancer Inst 60:955-960.
56. Hartmann LC, Schaid DJ, Woods JE, Crotty TP, Myers JL, Arnold PG, Petty PM, Sellers TA, Johnson JL, Michels VV, McDonnell SK, Frost MH, Jenkins RB. 1999. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med 340:77-84.
57. Hartmann LC, Sellers TA, Schaid DJ, Frank TS, Soderberg CL, Sitta DL, Frost MH, Grant CS, Donohue JH, Woods JE, McDonnell SK, Walsh Vockley C, Deffenbaugh A, Couch FJ, Jenkins RB. 2001. Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J Natl Cancer Inst 93:1633-1637.
58. 2 cell cycle checkpoint. Cancer Res 55:3721-3725.
59. Hemminki A, Tomlinson I, Markie D, Jarvinen H, Sistonen P, Bjorkqvist A-M, Knuutila S, Salovaara R, Bodmer W, Shibata D, de la Chapelle A, Aaltonen LA. 1997. Localization of a susceptibility locus for Peutz-Jeghers syndrome to 19p using comparative genomic hybridization and targeted linkage analysis. Nat Genet 15:87-90.
60. Hemminki A, Markie D, Tomlinson I, Avizienyte E, Roth S, Loukola A, Bignell G, Warren W, Aminoff M, Höglund P, Järvinen H, Kristo P, Pelin K, Ridanpää M, Salovaara R, Toro T, Bodmer W, Olschwang S, Olsen AS, Stratton MR, de la Chapelle A, Aaltonen LA. 1998. A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature 391:184-187.
61. Herrera L, Kakati S, Gibas L, Pietrzak E, Sandberg AA. 1986. Brief clinical report: Gardner's syndrome in a man with an interstitial deletion of 5q. Am J Med Genet 25:473-476.
62. Heston WE. 1956. Effects of genes located on chromosomes III, V, VII, IX, and XIV on the occurrence of pulmonary tumors in the mouse. Proc Int Genet Symp. Tokyo, Japan.
63. Heston WE. 1965. Genetic factors in the etiology of cancer. Cancer Res 25:1320-1326.
64. 1 hosts. J Natl Cancer Inst 11:1057-1071.
65. Hill MJ, Morson BC, Bussey HJR. 1978. Aetiology of adenoma-carcinoma sequence in large bowel. Lancet i:245-247.
66. Hirota S, Nishida T, Isozaki K, Taniguchi M, Nishikawa K, Ohashi A, Takabayashi A, Obayashi T, Okuno T, Kinoshita K, Chen H, Shinomura Y, Kitamura Y. 2002. Familial gastrointestinal stromal tumors associated with dysphagia and novel type germline mutation of KIT gene. Gastroenterology 122:1493-1499.
67. Horii A, Nakatsuru S, Miyoshi Y, Ichii S, Nagase H, Ando H, Yanagisawa A, Tsuchiya E, Kato Y, Nakamura Y. 1992. Frequent somatic mutations of the APC gene in human pancreatic cancer. Cancer Res 52:6696-6698.
68. Huang SC, Lavine JE, Boland PS, Newbury RO, Kolodner R, Pham TT, Arnold CN, Boland CR, Carethers JM. 2001. Germline characterization of early-aged onset of hereditary non-polyposis colorectal cancer. J Pediatr 138:629-635.
69. Isozaki K, Terris B, Belghiti J, Schiffmann S, Hirota S, Vanderwinden J-M. 2000. Germline-activating mutation in the kinase domain of KIT gene in familial gastrointestinal stromal tumors. Am J Pathol 157:1581-1585.
70. Jacob S, Praz F. 2002. DNA mismatch repair defects: role in colorectal carcinogenesis. Biochimie 84:27-47.
71. Jacobsen O. 1946. Heredity in breast cancer; a genetic and clinical study of two hundred probands. London: H.K. Lewis & Co., Ltd.
72. Jass JR. 1995a. Colorectal adenoma progression and genetic change: is there a link? Ann Med 27:301-306.
73. Jass JR. 1995b. Natural history of hereditary non-polyposis colorectal cancer. Journal Tumor Marker Oncology 10:65-71.
74. Jass JR, Stewart SM. 1992. Evolution of hereditary non-polyposis colorectal cancer. Gut 33:783-786.
75. Jass JR, Smyrk TC, Stewart SM, Lane MR, Lanspa SJ, Lynch HT. 1994a. Pathology of hereditary non-polyposis colorectal cancer. Anticancer Res 14:1631-1634.
76. Jass JR, Stewart SM, Stewart J, Lane MR. 1994b. Hereditary nonpolyposis colorectal cancer - morphologies, genes and mutations. Mutat Res 310:125-133.
77. Jenne DE, Reimann H, Nezu J, Friedel W, Loff S, Jeschke R, Müller O, Back W, Zimmer M. 1998. Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat Genet 18:38-44.
78. Joensuu H, Roberts PJ, Sarlomo-Rikala M, Andersson LC, Tervahartiala P, Tuveson D, Silberman S, Capdeville R, Dimitrijevic S, Druker B, Demetri GD. 2001. Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. N Engl J Med 344:1052-1056.
79. Järvinen HJ, Aarnio M, Mustonen H, Aktan-Collan K, Aaltonen LA, Peltomäki P, de la Chapelle A, Mecklin J-P. 2000. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 118:829-834.
80. Kauff ND, Satagopan JM, Robson ME, Scheuer L, Hensley M, Hudis CA, Ellis NA, Boyd J, Borgen PI, Barakat RR, Norton L, Offit K. 2002. Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 346:1609-1615.
81. Kinzler KW, Vogelstein B. 1996. Lessons from hereditary colon cancer. Cell 87:159-170.
82. Kinzler KW, Nilbert MC, Su L-K, Vogelstein B, Bryan TM, Levy DB, Smith KJ, Preisinger AC, Hedge P, McKechnie D, Finniear R, Markham A, Groffen J, Boguski MS, Altschul SF, Horii A, Ando H, Miyoshi Y, Miki Y, Nishisho I, Nakamura Y. 1991. Identification of FAP locus genes from chromosome 5q21. Science 253:661-665.
83. Krush A, Lynch HT, Magnuson C. 1965. Attitudes toward cancer in a "cancer family": implications for cancer detection. Am J Med Sci 249:432-438
84. Laken SJ, Petersen GM, Gruber SB, Oddoux C, Ostrer H, Giardiello FM, Hamilton SR, Hampel H, Markowitz A, Klimstra D, Jhanwar S, Winawer S, Offit K, Luce MC, Kinzler KW, Vogelstein B. 1997. Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC. Nat Genet 17: 79-83.
85. Lathrop AEC, Loeb L. 1913. The incidence of cancer in various strains of mice. Proc Soc Exp Biol Med 11:34-38.
86. Leach FS, Nicolaides NC, Papadopoulos N, Liu B, Jen J, Parsons R, Peltomaki P, Sistonen P, Aaltonen LA, Nystrom-Lahti M, Guan X-Y, Zhang J, Metzler PS, Yu J-W, Kao F-T, Chen DJ, Cerosaletti KM, Fournier REK, Todd S, Lewis T, Leach RJ, Naylor SL, Weissenbach J, Mecklin J-P, Jarvinen H, Petersen GM, Hamilton SR, Green J, Jass J, Watson P, Lynch HT, Trent JM, de la Chapelle A, Kinzler KW, Vogelstein B. 1993. Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 75:1215-1225.
87. Leclerc de Busson GL. 1749. Histoire naturelle générale et particuliére. Paris: Imprint Royale.
88. Leppert M, Burt R, Hughes J, Samowitz W, Nakamura Y, Woodward S, Gardner E, Lalouel J-M, White R. 1990. Genetic analysis of an inherited predisposition to colon cancer in a family with a variable number of adenomatous polyps. N Engl J Med 322:904-908.
89. Lewis RA, Crowder WE, Eierman LA. 1984. The Gardner syndrome. Significance of ocular features. Ophthalmology 91:916-925.
90. Li FP, Fraumeni JF. 1969. Soft-tissue sarcomas, breast cancer, and other neoplasms: a familial syndrome? Ann Intern Med 71:747-752.
91. Lindblom A, Tannergard P, Werelius B, Nordenskjold M. 1993. Genetic mapping of a second locus predisposing to hereditary nonpolyposis colorectal cancer. Nat Genet 5:279-282.
92. Lipkin M, Blattner WE, Fraumeni JF Jr, Lynch HT, Deschner E, Winawer S. 1983. Tritiated thymidine (phi p, phi h) labeling distribution as a market for hereditary predisposition to colon cancer. Cancer Res 43:1899-1904.
93. Lips CJM, Landsvater RM, Röppener JWM, Geerdink RA, Blijhani G, Jansen-Schillhorn van Veen JM, van Gils APG, de Wit MJ, Zewald RA, Berends MJH, Beemer FA, Brouwers-Smalbraak J, Jansen RPM, Van Amstel HKP, van Vroonhoven JMV, Vroom TM. 1994. Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A. N Engl J Med 331:828-835.
94. Lowenfels AB, Maisonneuve P, Cavallini G, Ammann RW, Lankisch PG, Andersen JR, DiMagno EP, Andrén-Sandberg A, Domellöf L, International Pancreatitis Study Group. 1993. Pancreatitis and the risk of pancreatic cancer. N Engl J Med 328:1433-1437.
95. Lowenfels AB, Maisonneuve P, Whitcomb DC, International Hereditary Pancreatitis Study Group. 2000. Risk factors for cancer in hereditary pancreatitis. Med Clin North Am 84:565-573.
96. Lynch HT. 1967. Hereditary factors in carcinoma. In: Lynch HT, editor. Recent results in cancer research. Vol. 12. New York: Springer-Verlag.
97. Lynch HT. 1969. Dynamic genetics counseling for clinicians. Springfield, Illinois: CC Thomas.
98. Lynch HT, editor. 1981. Genetics and breast cancer. New York: V. N. Reinhold Co.
99. Lynch HT. 1996. Is there a role for prophylactic subtotal colectomy among hereditary nonpolyposis colorectal cancer germline mutation carriers? Dis Colon Rectum 39: 109-110.
100. Lynch HT. 2001. Family Information Service and hereditary cancer. Cancer 91:625-628.
101. Lynch HT, de la Chapelle A. 1999. Genetic susceptibility to non-polyposis colorectal cancer. J Med Genet 36:801-818.
102. Lynch HT, de la Chapelle A. 2003. Genomic medicine: hereditary colorectal cancer. N Engl J Med 348:919-932.
103. Lynch HT, Fitzgibbons R, Jr. 1996. Surgery, desmoid tumors and familial adenomatous polyposis: case report and literature review. Am J Gastroenterol 91:2598-2601.
104. Lynch HT, Fusaro RM. 1991. Pancreatic cancer and the familial atypical multiple mole melanoma (FAMMM) syndrome. Pancreas 6:127-131.
105. Lynch HT, Fusaro RM. 1993. Muir-Torre syndrome: heterogeneity, natural history, diagnosis, and management. Prob Gen Surg 10:1-14.
106. Lynch HT, Hirayama T, editors. 1989. Genetic epidemiology of cancer. Boca Raton, FL: CRC Press, Inc.
107. Lynch HT, Krush AJ. 1968. Heredity and malignant melanoma: implications for early cancer detection. Can Med Assoc J 99:17-21.
108. Lynch HT, Krush AJ. 1971a. Cancer family "G" revisited: 1895-1970. Cancer 27:1505-1511.
109. Lynch HT, Krush AJ. 1971b. Carcinoma of the breast and ovary in three families. Surg Gynecol Obstet 133:644-648.
110. Lynch HT, Krush AJ. 1971c. Genetic predictability in breast cancer risk: surgical implications. Arch Surg 103:84-88.
111. Lynch HT, Tips RL, Krush AJ, Magnuson C. 1965. Family centered genetic counseling: role of the physician and the medical genetics clinic. Nebr State Med J 50:155.
112. Lynch HT, Shaw MW, Magnuson CW, Larsen AL, Krush AJ. 1966. Hereditary factors in cancer: study of two large Midwestern kindreds. Arch Intern Med 117:206-212.
113. Lynch HT, Krush AJ, Larsen AL. 1967. Heredity and multiple primary malignant neoplasms: six cancer families. Am J Med Sci 254:322-329.
114. Lynch HT, Krush AJ, Lemon HM, Kaplan AR, Condit PT, Bottomley RH. 1972. Tumor variation in families with breast cancer. JAMA 222:1631-1635.
115. Lynch HT, Krush AJ, Guirgis H. 1973. Genetic factors in families with combined gastrointestinal and breast cancer. Am J Gastroenterol 59:31-40.
116. Lynch HT, Guirgis HA, Brodkey F, Maloney K, Lynch PM, Rankin L, Lynch JF. 1976. Early age of onset in familial breast cancer: genetic and cancer control implications. Arch Surg 111:126-131.
117. Lynch PM, Lynch HT, Harris RE. 1977. Hereditary proximal colonic cancer. Dis Colon Rectum 20:661-668.
118. Lynch HT, Frichot BC, Lynch JF. 1978a. Familial atypical multiple mole-melanoma syndrome. J Med Genet 15:352-356.
119. Lynch HT, Lynch PM, Harris RE. 1978b. Minimal genetic findings and their cancer control implications: a family with the cancer family syndrome. JAMA 240:535-538.
120. Lynch HT, Mulcahy GM, Harris RE, Guirgis HA, Lynch JF. 1978c. Genetic and pathologic findings in a kindred with hereditary sarcoma, breast cancer, brain tumors, leukemia, lung, laryngeal, and adrenal cortical carcinoma. Cancer 41:2055-2064.
121. Lynch HT, Lynch PM, Albano WA, Edney J, Organ CH, Lynch JF. 1979. Hereditary cancer: ascertainment and management. CA Cancer J Clin 29:216-232.
122. Lynch HT, Lynch PM, Pester J, Fusaro RM. 1981. The cancer family syndrome: rare cutaneous phenotypic linkage of Torre's syndrome. Arch Intern Med 141:607-611.
123. Lynch HT, Lynch PM, Pester JA, Fusaro RM. 1982. Sebaceous neoplasia and visceral cancer (Torre's syndrome) and its relationship to the cancer family syndrome. In: Lynch HT, Fusaro RM, editors. Cancer-associated genodermatoses. New York: Van Nostrand Reinhold. p. 366-393.
124. Lynch HT, Drouhard TJ, Schuelke GS, Biscone KA, Lynch JF, Danes BS. 1985a. Hereditary nonpolyposis colorectal cancer in a Navajo Indian family. Cancer Genet Cytogenet 15:209-213.
125. Lynch HT, Fusaro RM, Roberts L, Voorhees GJ, Lynch JF. 1985b. Muir-Torre syndrome in several members of a family with a variant of the cancer family syndrome. Br J Dermatol 113:295-301.
126. Lynch HT, Katz D, Markvicka SE. 1985c. Familial mesothelioma: review and family study. Cancer Genet Cytogenet 15:25-35.
127. Lynch HT, Voorhees GJ, Lanspa SJ, McGreevy PS, Lynch JF. 1985d. Pancreatic carcinoma and hereditary nonpolyposis colorectal cancer: a family study. Br J Cancer 52:271-273.
128. Lynch HT, Kimberling WJ, Markvicka SE, Biscone KA, Lynch JF, Whorton E Jr, Mailliard J. 1986. Genetics and smoking-associated cancers. A study of 485 families. Cancer 57:1640-1646.
129. Lynch HT, Smyrk T, Lanspa SJ, Marcus JN, Kriegler M, Lynch JF, Appelman HD. 1988a. Flat adenomas in a colon cancer-prone kindred. J Natl Cancer Inst 80:278-282.
130. Lynch HT, Watson P, Lanspa SJ, Marcus JN, Smyrk TC, Fitzgibbons R Jr, Kriegler M, Lynch JF. 1988b. Natural history of colorectal cancer in hereditary nonpolyposis colorectal cancer (Lynch syndromes I and II). Dis Colon Rectum 31:439-444.
131. Lynch HT, Lanspa SJ, Fitzgibbons RJ Jr, Smyrk T, Fitzsimmons ML, McClellan J. 1989. Familial pancreatic cancer (part 1): genetic pathology review. Nebr Med J 74:109-112.
132. Lynch HT, Fitzsimmons ML, Smyrk TC, Lanspa SJ, Watson P, McClellan J, Lynch JF. 1990a. Familial pancreatic cancer: clinicopathologic study of 18 nuclear families. Am J Gastroenterol 85:54-60.
133. Lynch HT, Radford B, Lynch JF. 1990b. SBLA syndrome revisited. Oncology 47:75-79.
134. Lynch HT, Marcus JN, Watson P, Lynch J. 1991a. Familial breast cancer, cancer family syndromes, and predisposition to breast neoplasms. In: Bland K, Copeland EM, editors. The breast. Philadelphia: W.B. Saunders Co. p. 262-291.
135. Lynch PM, Wargovich MJ, Lynch HT, Palmer C, Lanspa S, Drouhard T, Lynch J. 1991b. A follow-up study of colonic epithelial proliferation as a biomarker in a Native-American family with hereditary nonpolyposis colorectal cancer. J Natl Cancer Inst 83:951-954.
136. Lynch HT, Drouhard T, Lanspa SJ, Lynch P, Bronson E, Lynch JF. 1992a. Lynch syndrome II in a Navajo family: a revisit. Am Indian Cult Res J 16:1-13.
137. Lynch HT, Smyrk TC, Watson P, Lanspa SJ, Lynch PM, Jenkins JX, Rouse J, Cavalieri J, Howard L, Lynch J. 1992b. Hereditary flat adenoma syndrome: a variant of familial adenomatous polyposis? Dis Colon Rectum 35:411-421.
138. Lynch HT, Drouhard T, Lanspa S, Smyrk T, Lynch P, Lynch J, Vogelstein B, Nyström-Lahti M, Sistonen P, Peltomäki P, de la Chapelle A. 1994. Mutation of an mutL homologue in a Navajo family with hereditary nonpolyposis colorectal cancer. J Natl Cancer Inst 86: 1417-1419.
139. Lynch HT, Drouhard T, Vasen HFA, Cavalieri J, Lynch J, Nord S, Smyrk T, Lanspa S, Murphy P, Whelan KL, Peters J, de la Chapelle A. 1996a. Genetic counseling in a Navajo hereditary nonpolyposis colorectal cancer kindred. Cancer 77:30-35.
140. Lynch HT, Smyrk T, Kern SE, Hruban RH, Lightdale CJ, Lemon SJ, Lynch JF, Fusaro LR, Fusaro RM, Ghadirian P. 1996b. Familial pancreatic cancer: a review. Sera Oncol 23:251-275.
141. Lynch HT, Lin K, Smyrk T, Watson P, Thorson A, Shashidharan M, Franklin B, Karr B, Lynch J, Tinley S, Lanspa S, Lemon S, Rodriguez-Bigas MA. 1997. Colorectal cancer, pathology staging and survival in HNPCC. ASCO Program/Proceedings 16:530a (abstract).
142. Lynch HT, Smyrk T, Lynch JF. 1998. Molecular genetics and clinical-pathology features of hereditary nonpolyposis colorectal carcinoma (Lynch syndrome): historical journey from pedigree anecdote to molecular genetic confirmation. Oncology 55: 103-108.
143. Lynch HT, Leibowitz R, Smyrk T, Fusaro RM, Lynch JF, Smith A, Franklin B, Stella A, Liu B. 1999. Colorectal cancer and the Muir-Torre syndrome in a Gypsy family: a review. Am J Gastroenterol 94:575-580.
144. Lynch HT, Brand RE, Deters CA, Shaw TG, Lynch JF. 2001a. Hereditary pancreatic cancer. Pancreatology 1:466-471.
145. Lynch HT, Lynch JF, Rubinstein WS. 2001b. Prophylactic mastectomy: obstacles and benefits. J Natl Cancer Inst 93:1586-1587.
146. Lynch HT, Brand RE, Hogg D, Deters CA, Fusaro RM, Lynch JF, Liu L, Knezetic J, Lassam NJ, Goggins M, Kern S. 2002. Phenotypic variation in eight extended CDKN2A germline mutation familial atypical multiple mole melanoma-pancreatic carcinoma-prone families: the familial atypical multiple mole melanoma-pancreatic carcinoma syndrome. Cancer 94:84-96.
147. Lynch HT, Deters CA, Hogg D, Lynch JF, Kinarsky Y, Gatalica Z. 2003. Familial sarcoma: challenging pedigrees. Cancer 98:1947-1957.
148. Lynch HT, Coronel SM, Okimoto K, Hampel H, Sweet K, Lynch JF, Barrows A, Fodde R, Wagner A, Wijnen J, van der Klift H, Franken P, de la Chapelle A. 2004. An American founder mutation of the MSH2 gene may account for a significant proportion of all Lynch syndrome cases in the United States. JAMA 291:718-724.
149. Macklin MT. 1959. Comparison of the number of breast-cancer deaths observed in relatives of breast-cancer patients, and the number expected on the basis of mortality rates. J Natl Cancer Inst 22:927-951.
150. Macklin MT. 1960. Inheritance of cancer of stomach and large intestine in man. J Natl Cancer Inst 24:551-571.
151. Marra G, Boland CR. 1995. Hereditary non-polyposis colorectal cancer: the syndrome, the genes, and historical perspectives. J Natl Cancer Inst 87:1114-1125.
152. McKusick VA. 1998. Mendelian inheritance in man: a catalog of human genes and genetic disorders. 12th ed. Baltimore: The Johns Hopkins University Press. p. 1260.
153. Meijers-Heijboer H, van Geel B, van Putten WLJ, Henzen-Logmans SC, Seynaeve C, Menke-Pluymers MBE, Bartels CCM, Verhoog LC, van den Ouweland AMW, Niermeijer MF, Brekelmans CTM, Klijn JGM. 2001. Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 345:159-164.
154. Meijers-Heijboer H, Wijnen J, Vasen H, Wasielewski M, Wagner A, Hollestelle A, Elstrodt F, van den Bos R, de Snoo A, Tjon A, Fat G, Brekelmans C, Jagmohan S, Franken P, Verkuijlen P, van den Ouweland A, Chapman P, Tops C, Moslein G, Burn J, Lynch H, Klijn J, Fodde R, Schutte M. 2003. The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotype. Am J Hum Genet 72:1308-1314.
155. Menzelio D. 1721. De excrescentals verrucosa cristosis in intestinis crassis dysenteriam passi observatis. Ast Med Berolinensium 4:68-71.
156. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, Bell R, Rosenthal J, Hussey C, Tran T, McClure M, Frye C, Hattier T, Phelps R, Haugen-Strano A, Katcher H, Yakumo K, Gholami Z, Shaffer D, Stone S, Bayer S, Wray C, Bogden R, Dayananth P, Ward J, Tonin P, Narod S, Bristow PK, Norris FH, Helvering L, Morrison P, Rosteck P, Lai M, Barrett JC, Lewis C, Neuhausen S, Cannon-Albright L, Goldgar D, Wiseman R, Kamb A, Skolnick MH. 1994. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66-71.
157. Miyaki M, Konishi M, Tanaka K, Kikuchi-Yanoshita R, Muraoka M, Yasuno M, Igari T, Koike M, Chiba M, Mori T. 1997. Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer. Nat Genet 17:271-272.
158. Morse RP. 1999. Neurofibromatosis type 1. Arch Neurol 56:364-365.
159. Morson BC, Bussey HJR, Day DW, Hill MJ. 1983. Adenomas of large bowel. Cancer Surv 2:451-477.
160. Mulligan LM, Kwok JBJ, Healey CS, Elsdon MJ, Eng C, Gardner E, Love DR, Mole SE, Moore JK, Papl L, Ponder MA, Telenius H, Tunnacliffe A, Ponder BAJ. 1993. Germline mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 363:458-460.
161. Mulvihill JJ. 1978. Host factors in human lung tumors: an example of ecogenetics in oncology. J Natl Cancer Inst 57:3-7.
162. Mulvihill JJ. 1982. Ecogenetic origins of cancer in the young: environmental and genetic determinants. In: Levine AS, editor. Cancer in the young. New York: Masson. p. 13-27.
163. Mulvihill JJ, Chaliha I, Weddn A, Feldman A, Aston C, Virijii M. 2000. Ecogenetics of familial pancreatic cancer. Pancreas 21:464 (abstract).
164. Muto T, Kamiya J, Sawada T, Konishi F, Sugihara K, Kubota Y, Adachi M, Agawa S, Saito Y, Morioka Y, Tanprayoon T. 1985. Small "flat adenoma" of the large bowel with special reference to its clinicopathologic features. Dis Colon Rectum 28:847-851.
165. Narod SA, Feunteun J, Lynch HT, Watson P, Conway T, Lenoir GM. 1991. Familial breast-ovarian cancer locus on chromosome 17q12-q23. Lancet 388:82-83.
166. Nishida T, Hirota S, Taniguchi M, Hashimoto K, Isozaki K, Nakamura H, Kanakura Y, Tanaka T, Takabayashi A, Matsuda H, Kitamura Y. 1998. Familial gastrointestinal stromal tumours with germline mutation of the KIT gene. Nat Genet 19:323-324.
167. Norris W. 1820. Case of fungoid disease. Edinburgh Med Surg J 16:562-565.
168. Nystrom-Lahti M, Parsons R, Sistonen P, Pylkkanen L, Aaltonen LA, Leach FS, Hamilton SR, Watson P, Bronson E, Fusaro R, Cavalieri J, Lynch J, Lanspa SJ, Smyrk T, Lynch P, Drouhard T, Kinzler KW, Vogelstein B, Lynch HT, de la Chapelle A, Peltomaki P. 1994. Mismatch repair genes on chromosomes 2p and 3p account for a major share of hereditary nonpolyposis colorectal cancer families evaluable by linkage. Am J Hum Genet 55:659-665.
169. Papadopoulos N, Nicolaides NC, Wei Y-F, Ruben SM, Carter KC, Rosen CA, Haseltine WA, Fleishmann RD, Fraser CM, Adams MD, Venter JC, Hamilton SR, Petersen M, Watson P, Lynch HT, Peltomaki P, Mecklin JP, de la Chapelle A, Kinzler KW, Vogelstein B. 1994. Mutation of a mutL homolog in hereditary colon cancer. Science 263:1625-1629.
170. Paré A. 1585. Les Oeuvres d'Ambroise Paré, Conseiller et Premier Chirurgien du Roy. Divisées en vingt huigt livres. Avec les figures et portraicts, tant de l'Anatomie, que des instruments de Chirurgie, et des plusiers Monstres. Paris: Chez Gabriel Buon.
171. Peltomäki P, Aaltonen L, Sistonen P, Pylkkänen L, Mecklin J-P, Järvinen H, Green JS, Jass JR, Weber JL, Leach FS, Petersen GM, Hamilton SR, de la Chapelle A, Vogelstein B. 1993. Genetic mapping of a locus predisposing to human colorectal cancer. Science 260:810-812.
172. Prior TW, Chadwick RB, Papp AC, Arcot AN, Isa AM, Pearl DK, Stemmermann G, Percesepe A, Loukola A, Aaltonen LA, de la Chapelle A. 1999. The I1307K polymorphism of the APC gene in colorectal cancer. Gastroenterology 116:58-63.
173. Rebbeck TR, Levin AM, Eisen A, Snyder C, Watson P, Cannon-Albright L, Isaacs C, Olopade O, Garber JE, Godwin AK, Daly MB, Narod SA, Neuhausen SL, Lynch HT, Weber BL. 1999. Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers. J Natl Cancer Inst 91:1475-1479.
174. Rebbeck TR, Lynch HT, Neuhausen SL, Narod SA, van't Veer L, Garber JE, Evans G, Isaacs C, Daly MB, Matloff E, Olopade OI, Weber BL, for The Prevention and Observation of Surgical End Points Study Group. 2002. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. N Engl J Med 346:1616-1622.
175. Reimer RR, Clark WH Jr, Greene MH, Ainsworth AM, Fraumeni JF, Jr. 1978. Precursor lesions in familial melanoma. A new genetic preneoplastic syndrome. JAMA 239:744-746.
176. Ribic CM, Sargent DJ, Moore MJ, Thibodeau SN, French AJ, Goldberg RM, Hamilton SR, Laurent-Puig P, Gryfe R, Shepherd LE, Tu D, Redston M, Gallinger S. 2003. Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med 349:247-257.
177. Riccardi VM, Eichner JE. 1986. Neurofibromatosis: phenotype, natural history and pathogenesis. Baltimore, MD: Johns Hopkins University Press.
178. Rodriguez-Bigas MA, Boland CR, Hamilton SR, Henson DE, Jass JR, Khan PM, Lynch H, Perucho M, Smyrk T, Sobin L, Srivastava S. 1997. A National Cancer Institute workshop on hereditary nonpolyposis colorectal cancer syndrome: meeting highlights and Bethesda Guidelines. J Natl Cancer Inst 89: 1758-1762.
179. Rodriguez-Bigas MA, Vasen HFA, Lynch HT, Watson P, Myrhøj T, Järvinen HJ, Mecklin JK, Macrae F, St. John DJB, Bertario L, Fidalgo P, Madlensky L, Rozen P, International Collaborative Group on HNPCC. 1998. Characteristics of small bowel carcinoma in hereditary nonpolyposis colorectal carcinoma. Cancer 83:240-244.
180. Rossi CR, Mocellin S, Mencarelli R, Foletto M, Pilati P, Nitti D, Lise M. 2003. Gastrointestinal stromal tumors: from a surgical to a molecular approach. Int J Cancer 107:171-176.
181. Rozen P, Shomrat R, Strul H, Naiman T, Karminsky N, Legum C, Orr-Urtreger A. 1999. Prevalence of the I1307K APC gene variant in Israeli Jews of differing ethnic origin and risk for colorectal cancer. Gastroenterology 116:54-57.
182. Ruggieri M, Huson SM. 2001. The clinical and diagnostic implications of mosaicism in the neurofibromatoses. Neurology 56:1433-1443.
183. Ruggieri M, Polizzi A. 2003. From Aldrovandi's "Homuncio" (1592) to Buffon's girl (1749) and the "Wart Man" of Tilesius (1793): antique illustrations of mosaicism in neurofibromatosis? J Med Genet 40:227-232.
184. Sarroca C, Ferreira WA, Quadrelli R. 1977. Cáncer colónico familiar sin poliposis: enfoque clínico y anátomo- patológico. Perspectivas de estudio genético. Cir del Uruguay 47:515-520.
185. Sarroca C, Alfano N, Bendin GT, Della Valle A, Dominguez C, Quadrelli R, Vaglio A, Mechoso B, Tinley ST, Harty AE, Lynch JF, Franklin BA, Kristo P, Smyrk TC, Peltomäki P, Lynch HT. 2000. Hereditary nonpolyposis colorectal cancer (Lynch syndrome II) in Uruguay. Dis Colon Rectum 43:353-362.
186. Sato N, Rosty C, Jansen M, Fukushima N, Ueki T, Yeo CJ, Cameron JL, Iacobuzio-Donahue CA, Hruban RH, Goggins M. 2001. Peutz-Jeghers gene inactivation in intraductal papillary-mucinous neoplasms of the pancreas. Am J Pathol 159:2017-2022.
187. Schutte M, Hruban RH, Geradts J, Maynard R, Hilgers W, Rabindran SK, Moskaluk CA, Hahn SA, Schwarte-Waldhoff I, Schmiegel W, Baylin SB, Kern SE, Herman JG. 1997. Abrogation of the Rb/p16 tumor suppressive pathway in virtually all pancreatic carcinomas. Cancer Res 57:3126-3130.
188. Sipple JH. 1961. The association of pheochromocytoma with carcinoma of the thyroid gland. Am J Med 31:163-166.
189. Smith T 1887. Three cases of multiple polypi of the lower bowel occurring in one family. St Bartholomew's Hosp Rep 23:225-229.
190. Smyrk TC, Watson P, Kaul K, Lynch HT. 2001. Tumor-infiltrating lymphocytes are a marker for microsatellite instability in colorectal cancer. Cancer 91:2417-2422.
191. Spirio L, Otterud B, Stauffer D, Lynch H, Lynch P, Watson P, Lanspa S, Smyrk T, Cavalieri J, Howard L, Burt R, White R, Leppert M. 1992. Linkage of a variant or attenuated form of adenomatous polyposis coli to the adenomatous polyposis coli (APC) locus. Am J Hum Genet 51:92-100.
192. Spirio L, Olschwang S, Groden J, Robertson M, Samowitz W, Joslyn G, Gelbert L, Thliveris A, Carlson M, Otterud B, Lynch H, Watson P, Lynch P, Laurent-Puig P, Burt R, Hughes JP, Thomas G, Leppert M, White R. 1993. Alleles of the APC gene: an attenuated form of familial polyposis. Cell 75:951-957.
193. Stephens FE, Gardner EJ, Woolf CM. 1958. A recheck of kindred 107, which has shown a high frequency of breast cancer. Cancer 11:967-972.
194. Su GH, Hruban RH, Bova GS, Goggins M, Bansal RK, Tang DT, Shekher MC, Entius MM, Yeo CJ, Kern SE. 1999. Germline and somatic mutations of the STK11/LKB1 Peutz-Jeghers gene in pancreatic and biliary cancers. Am J Pathol 154:1835-1840.
195. Swift M, Sholman L, Perry M, Chase C. 1976. Malignant neoplasms in the families of patients with ataxia telangiectasia. Cancer Res 36:209-215.
196. Tempero MA, Jacobs MM, Lynch HT, Graham CL, Blotcky AJ. 1984. Serum and hair selenium levels in hereditary nonpolyposis colorectal cancer. Biol Trace Elem Res 6: 51-55.
197. Tersmette AC, Petersen GM, Offerhaus GJA, Falatko FC, Brune KA, Goggins M, Rozenblum E, Wilentntz RE, Yeo CJ, Cameron JL, Kern SE, Hruban RH. 2001. Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer. Clin Cancer Res 7:738-744.
198. Thorson A, Knezetic JA, Lynch HT. 1999. A century of progress in hereditary nonpolyposis colorectal cancer (Lynch syndrome). Dis Colon Rectum 42:1-9.
199. Tilesius von Tilenau WG. 1793. Historia Pathologica Singlularis Cutis Turpitudinis: Jo Godofredi Rheinhardt viri Lannorum. Leipzig, Germany: SL Crucius.
200. Tulinius H, Olafsdottir GH, Sigvaldason H, Tryggvadottir L, Bjarnadottir K. 1994. Neoplastic diseases in families of breast cancer patients. J Med Genet 31:618-621.
201. Utsunomiya J, Nakamura T. 1975. The occult osteomatous changes in the mandible in patients with familial polyposis coli. Br J Surg 62:45-51.
202. Vasen HFA, Mecklin J-P, Meera Khan P, Lynch HT. 1991. The International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum 34:424-425.
203. Vasen HFA, Watson P, Mecklin J-P, Khan PM, Lynch HT. 1994. The International Collaborative Group on HNPCC. Anticancer Res 14:1661-1664.
204. Vasen HFA, Nagengast FM, Khan PM. 1995. Interval cancers in hereditary non-polyposis colorectal cancer (Lynch syndrome). Lancet 345:1183-1184.
205. Vasen HFA, Watson P, Mecklin J-P, Lynch HT, ICG-HNPCC. 1999. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative Group on HNPCC. Gastroenterology 116:1453-1456.
206. Vasen HFA, Gruis NA, Frants RR, van der Velden PA, Hille ETM, Bergman W. 2000. Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16-Leiden). Int J Cancer 87:809-811.
207. Vogelstein B, Kinzler KW, editors. 1998. The genetic basis of human cancer. New York: McGraw-Hill.
208. Wagner A, Barrows A, Wijnen JT, van der Klift H, Franken PF, Verkuijlen P, Nakagawa H, Geugien M, Jaghmohan-Changur S, Breukel C, Meijers-Heijboer H, Morreau H, van Puijenbroek M, Burn J, Coronel S, Kinarski Y, Okimoto R, Watson P, Lynch JF, de la Chapelle A, Lynch HT, Fodde R. 2003. Molecular analysis of hereditary nonpolyposis colorectal cancer in the United States: high mutation detection rate among clinically selected families and characterization of an American founder genomic deletion of the MSH2 gene. Am J Hum Genet 72: 1088-1100.
209. Warthin AS. 1913. Heredity with reference to carcinoma as shown by the study of the cases examined in the pathological laboratory of the University of Michigan, 1895-1913. Arch Intern Med 12:546-555.
210. Warthin AS. 1925. The further study of a cancer family. J Cancer Res 9:279-286.
211. Watson P, Lynch HT. 1994. The tumor spectrum in HNPCC. Anticancer Res 14:1635-1640.
212. Watson P, Lin K, Rodriguez-Bigas MA, Smyrk T, Lemon S, Shashidharan M, Franklin B, Karr B, Thorson A, Lynch HT. 1998. Colorectal carcinoma survival among hereditary nonpolyposis colorectal cancer family members. Cancer 83:259-266.
213. Wells SA Jr, Chi DD, Toshima K, Dehner LP, Coffin CM, Dowton SB, Ivanovich JL, DeBenedetti MK, Dilley WG, Moley JE Norton JA, Donis-Keller H. 1994. Predictive DNA testing and prophylactic thyroidectomy in patients at risk for multiple endocrine neoplasia type 2A. Ann Surg 220: 237-250.
214. Whitcomb DC, Gorry MC, Preston RA, Furey W, Sossenheimer MJ, Ulrich CD, Martin SP, Gates LK Jr, Amann ST, Toskes PP, Liddle R, McGrath K, Uomo G, Post JC, Ehrlich GD. 1996. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Genet 14:141-145.
215. Williams ED. 1966. Histogenesis of medullary carcinoma of the thyroid. J Clin Pathol 19: 114-118.
216. Wolfe HJ, Melvin KEW, Cervi-Skinner SJ, Saadi AA, Juliar JF, Jackson CE, Tashjian AH, Jr. 1973. C-cell hyperplasia preceding medullary thyroid carcinoma. N Engl J Med 289: 437-441.
217. Woodward JJ. 1881. Pseudo-polypi of the colon: an anomalous result of follicular ulceration. Am J Med Sci 81:142-155.
218. Wooster R, Neuhausen SL, Mangion J, Quirk Y, Ford D, Collins N, Nguyen K, Seal S, Tran T, Averill D, Fields P, Marshall G, Narod S, Lenoir GM, Lynch H, Feunteun J, Devilee P, Cornelisse CJ, Menko FH, Daly PA, Ormiston W, McManus R, Pye C, Lewis CM, Cannon-Albright LA, Peto J, Ponder BAJ, Klolnick MH, Easton DF, Goldgar DE, Stratton MR. 1994. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 265:2088-2090.
219. Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, Gregory S, Gumbs C, Micklem G, Barfoot R, Hamoudi R, Patel S, Rice C, Biggs P, Hashim T, Smith A, Connor F, Arason A, Gudmundsson J, Ficenec D, Kelsell D, Ford D, Tonin P, Bishop DT, Spurr NK, Ponder BAJ, Eeles R, Peto J, Devilee P, Cornelisse C, Lynch H, Narod S, Lenoir G, Egilsson V, Bjork Barkadottir R, Easton DF, Bentley DR, Futreal PA, Ashworth A, Stratton MR. 1995. Identification of the breast cancer susceptibility gene BRCA2 [Comments] [published Erratum appears in Nature 1996;379:749]. Nature 378:789-792.
220. Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, Gregory S, Gumbs C, Micklem G, Barfoot R, Hamoudi R, Patel S, Rice C, Biggs P, Hashim T, Smith A, Connor F, Arason A, Gudmundsson J, Ficenec D, Kelsell D, Ford D, Tonin P, Bishop DT, Spurr NK, Ponder BAJ, Eeles R, Peto J, Devilee P, Cornelisse C, Lynch H, Narod S, Lenoir G, Egilsson V, Bjork Barkadottir R, Easton DF, Bentley DR, Futreal PA, Ashworth A, Stratton MR. 1995. Identification of the breast cancer susceptibility gene BRCA2 [Comments] [published Erratum appears in Nature 1996;379:749]. Nature 378:789-792.
221. Yan H, Papadopoulos N, Marra G, Perrera C, Jiricny J, Boland CR, Lynch HT, Chadwick RB, de la Chapelle A, Berg K, Eshleman JR, Yuan W, Markowitz S, Laken SJ, Lengauer C, Kinzler KW, Vogelstein B. 2000. Conversion of diploidy to haploidy: individuals susceptible to multigene disorders may now be spotted more easily. Nature 403:723-724.
222. Yashima K, Nakamori S, Murakami Y, Yamaguchi A, Hayashi K, Ishikawa O, Konishi Y, Sekiya T. 1994. Mutations of the adenomatous polyposis coli gene in the mutation cluster region: comparison of human pancreatic and colorectal cancers. Int J Cancer 59:43-47.
223. Zanca A, Zanca A. 1977. Iconografia dermatologica del passato. Antiche illustrazioni di neurofibromatosi multipla. Chron Dermatol 2:282.